Rare diseases
Investigational molecules
Locations
Arthur Van Gehuchtenplein 4, 1020 Brussels, Belgium
Association Hospitaliere De Bruxelles Et De Schaerbeek Centre Hospitalier Universitaire Brugmann in Brussels, Belgium specialises in clinical trials of conditions such as Arteriosclerosis, Non-small cell lung cancer stage IV, Neoplasm, Breast cancer, and other specialisations. This site conducts important research.
The Association Hospitaliere De Bruxelles Et De Schaerbeek Centre Hospitalier Universitaire Brugmann is advancing knowledge in Cardiovascular Diseases, targeting conditions such as Atherosclerotic Cardiovascular Disease and elevated lipoprotein(a). Ongoing studies evaluate whether novel agents like Lepodisiran can lower the risk of major adverse cardiac events.
Researchers at the Brussels site are testing innovative therapies to improve heart health and reduce cardiovascular mortality.
In the realm of Respiratory Tract Diseases, the department concentrates on severe allergic and eosinophilic asthma. Comparative trials assess the effectiveness of biologics such as omalizumab and mepolizumab in decreasing severe exacerbations.
This research aims to personalize asthma management and enhance quality of life for patients in Brussels.
Clinical trials currently enrolling participants at this site.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
